Delivery Order SPE2DB22D3401-SPE2DB23FT4QM
Award Date 8/12/23
Potential Completion Date 8/14/23
Potential Value $3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $2,516 to Amerisourcebergen Drug Corporation to supply 4561919250 CAPLYTA 42 MG CAPSULE 30S. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 24, 2023 under the terms of the contract. The Defense Logistics Agency functions to support America's armed forces by procuring their necessary supplies and equipment,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $976 to Amerisourcebergen Drug Corporation to supply 4561774028 CAPLYTA 42 MG CAPSULE 30S. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 11, 2023 under the contract start and end dates. The Defense Logistics Agency is the funding agency for this requirement to support its logistics and procurement missions. No...
- The Defense Logistics Agency awarded a $1,278.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units). AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected through competitive procurement with no set-aside designation. The delivery order has an ultimate completion date of July 23, 2025, with performance at the contractor's Conshohocken...
- The Defense Logistics Agency awarded a $2,964.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561569996 CAPLYTA 21 MG CAPSULE 30S. The order was placed under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and DoD customers. Amerisourcebergen will deliver the specified medication to a customer located in Conshohocken, Pennsylvania, with performance required between July 21-24, 2023. No socioeconomic designations or...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,543.88 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units) under a firm fixed-price contract. The award was made on September 22, 2025, with an ultimate completion date of September 23, 2025, and represents a non-set-aside competitive procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $5,153.50 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 4561454927 capsules of CAPLYTA, a 21mg antipsychotic medication, for delivery to a facility located in Conshohocken, Pennsylvania. The single delivery is to be completed by July 11, 2023. As a major supplier of pharmaceuticals and medical supplies to the U.S. Department of Defense, this order for CAPLYTA capsules...
- The Defense Logistics Agency Troop Support Medical awarded a $1,951.38 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 capsules of the pharmaceutical CAPLYTA in a 42 mg dosage. The order is to be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania by September 21, 2023 in support of the Defense Logistics Agency's medical supply chain responsibilities. No subcontractors or set aside designations were indicated. The delivery order is a...
- The Defense Logistics Agency awarded a $2,096.12 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561851089 CAPLYTA 42 MG CAPSULE 30S. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the requested pharmaceutical products from its Conshohocken, Pennsylvania facility to the Defense Logistics Agency by August 18, 2023 to support the agency's medical supply needs. No set aside designation or subcontractors were identified for this small purchase order...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $35,633.13 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 4561771306 CAPLYTA 42 MG CAPSULE 30S to an agency location in Conshohocken, Pennsylvania. The performance period is from August 10, 2023 through August 11, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor without involvement from...
- This firm fixed price delivery order, valued at $46,147.56, was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp Corporate Office Division for the delivery of 4562092786 CAPLYTA 42 MG CAPSULE 30S. The Defense Logistics Agency, which supports the Department of Defense, issued this order under an unspecified multiple award contract vehicle to fulfill its pharmaceutical supply needs. Performance will take place in Conshohocken, Pennsylvania over a three day period from...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB23FT4QMDelivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $3,000 to Amerisourcebergen Drug Corporation to supply 4561791682 CAPLYTA 42 MG CAPSULE 30S. The order was placed under an existing Amerisourcebergen Corporation indefinite-delivery/indefinite-quantity contract vehicle and will be performed in Conshohocken, Pennsylvania from August 12-14, 2023. As a leading provider of pharmaceuticals and medical supplies to the Department of Defense, this order supports DLA's mission to provide critical medications to military treatment facilities on schedule and at lowest cost. No subcontractors or set-aside designations were identified.
Generated 12/24/23, 3:52 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 8/12/23 |